CytomX Therapeutics Inc News - CTMX

Get an advanced news scanner tailored to your needs by ADVFN

Enhance your trading experience

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

SOUTH SAN FRANCISCO, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a...

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is...

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

SOUTH SAN FRANCISCO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a...

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

- Initiation of GLP toxicology study for the first clinical candidate in the collaboration triggers a $5...

Form S-8 - Securities to be offered to employees in employee benefit plans

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data in solid tumors anticipated in the 2nd...

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher

In Monday’s pre-market trading, U.S. index futures are indicating a downward move, following the worst...

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a...

CytomX Therapeutics to Present at Upcoming March Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a...

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

- Initiation of CX-2051 Phase 1 clinical study in EpCAM positive tumors including colorectal cancer anticipated...

Form 4 - Statement of changes in beneficial ownership of securities

Monksdream 2 months ago

CTMX under $2

👍️0

Monksdream 7 months ago

CTMX under $2

👍️0

Triple nickle 10 months ago

Added some,jus have a feeling for two weeks now.

👍️0

surf1944 1 year ago

https://stockcharts.com/h-sc/ui?s=ctmx&p=D&yr=0&mn=6&dy=0&id=p38090673899

https://www.barchart.com/stocks/quotes/ctmx/technical-chart?plot=CANDLE&volume=total&data=DO&density=ML&pricesOn=1&asPctChange=0&logscale=0&indicators=ACCUM;SMA(20);SMA(50);SMA(100);SMA(200);CHKMF(20)&sym=SYSX&grid=1&height=210&studyheight=100

https://www.barchart.com/stocks/quotes/ctmx/opinion

Still has one last open gap at $1.20 area

👍️0

alstocks 1 year ago

Ho hum… just another billion dollar

big pharma company giving millions to little

old ctmx…. Along with regeneron, moderna,

abbvie…. I’m sure the shorts will find a way

to drag this down today….

Good luck to all

👍️0

MightyX 1 year ago

CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

👍️0

alstocks 1 year ago

Fwiw, buying more…. This is largest

position in my portfolio…. Not getting angry

at the insanity of selling/shorting…

buying more…. & will continue buying more

if it goes lower….

Unbelievable 2 prs…. Moderna & regeneron

Giving this company 60 million dollars &

both prs 8-k’d…..

Good luck to all

👍️0

alstocks 1 year ago

Kind of unbelievable when you actually read

it…. See 8-k on 1-5-2023….

https://ih.advfn.com/stock-market/NASDAQ/cytomx-therapeutics-CTMX/stock-news/89920696/current-report-filing-8-k

“Under the terms of the Collaboration and License Agreement, Moderna will make an upfront cash payment to the Company of $35 million, including $5 million of pre-paid research funding. The Company will be eligible to receive future development, regulatory and commercial….”

and this is the second deal like this that the
company has received from a big company (regeneron the other)

Good luck to all

👍️0

1hot toddy 1 year ago

look at vygr we r going to be just like them $10 here we come $$$$$$$$$$$$$$$

👍️0

alstocks 1 year ago

Fwiw, confirmation on J.P. Morgan

presentation…. Today at 6 pm est

https://ir.cytomx.com/events-and-presentations

Good luck to all

👍️0

alstocks 1 year ago

When this happens tommorrow…

we will soar again

https://www.globenewswire.com/en/news-release/2022/01/05/2361610/37704/en/CytomX-Therapeutics-to-Present-at-the-40th-Annual-J-P-Morgan-Healthcare-Conference.html

Good luck to all

👍️0

dinogreeves 1 year ago

They have over 200 million dollars in the coffers bro, look at the pipeline, that is not a small potato. I remember taking a position on MRN*A right around covid and at the time Moderna had a similar share structure, Moderna low was around 4.80, I ended up buying at 16 dollars and touted it will hit triple dollars with patience and they had 300 million in the coffers. This stock is buy accumulate and wait for 20.....30......and eventually it will hit 40-50 dollars given time. Moderna takes a stake in this company, game over it will run big. Plus there are other big cap biotechs that are bankrolling this company, company has already indicated cash runway good till 2025. I am buying and accumulating what I can cause I know this one is going to do wonders.

https://cytomx.com/pipeline/

👍️0

Hercules1 1 year ago

$5 here next week.

There is no need for an offering.

👍️0

TheFinalCD 1 year ago

when was the last offering?

👍️0

alstocks 1 year ago

Today was overdue…. Should have

happened with the moderna news during

normal hours… instead it went from 2.90 to

2.40 !?!?!?…. this is ABSOLUTELY the best

“Penny” stock to own…. unbelievable 2 prs

in the past 2 mths…. was 1.20 when the prs

started…. Still way undervalued… read the

moderna & regeneron pRS and then go

WOW, 2 of the biggest companies in there

respective industry just handed this small

company at 1.20 a share 60 Million

DOLLARs

Good luck to all

👍️0

TheFinalCD 1 year ago

thats what gives me some more confidence against an offering

not that they wont

because we have seen some be cash FLU$H and still offer

👍️0

crudeoil24 1 year ago

Finally CTMX gaining traction. Company sitting on multi-millions $CASH$.

👍️0

dinogreeves 1 year ago

I have been loading big since last week and still are. Massive move coming 15-20 short term and eventually will hit 30-40 dollars by year end.

👍️0

Hercules1 1 year ago

$CTMX:

This will triple in price in the coming days.

Time to load up is now.

👍️0

TheFinalCD 1 year ago

FEELS LIKE $3 TEST COMING

👍️0

TheFinalCD 1 year ago

hopefully runs for 2 fist lol

👍️0

tw0122 1 year ago

Wait for $1.90s to reload for next run

👍️0

dinogreeves 1 year ago

CTMX, is one of the best stock right now in the sector to own over short, mid, and especially over long term. 15 indications of pipeline and over 200 million dollars in cash, with host of major blue chip companies are the backbone of this science, as of late Moderna. Hands down the one to be in and I will be accumulating anything under $3.00. Give this ticker 6-9 months it will be trading with ease above $20.00.

👍️ 1

TheFinalCD 1 year ago

$CTMX 2.60 BREAK

👍️0

Triple nickle 1 year ago

Uh oh see ya at 2.20

👍️0

Triple nickle 1 year ago

Y’all beat the horses
I’ll make bank

👍️0

Triple nickle 1 year ago

Added again

👍️0

surf1944 1 year ago

CTMX like most small cap biotech/pharma stocks the charts are full of gaps, if you check the trading history of CTMX that have all filled except one. The one on the 12/12/2022 is a point to view the traders took it down quickly to fill that open gap. It doesn't mean it fills today, but it is likely you will have overhang until it does. The CTMX holders that looked at their accounts today see it up 100% they take advantage of that in the short term, it doesn't say they are gone just that profits may have been taken.

👍️0

alstocks 1 year ago

Again, to beat a dead horse… let me

summarize…. AGAIN… ctmx released the

greatest Legit PR of all time ( no

exaggeration ) … 2 months after releasing

the first greatest Pr of all time…and after

that 2nd Pr was released… stock is literally

crashing from 2.90 down to now 2.48…

I want to put my fist through a wall right now

(And I bought at 1.50)… & I’m still pissed

Good luck to all

👍️0

Triple nickle 1 year ago

One day rsi gunna start curlin upward baby

👍️0

Triple nickle 1 year ago

Added

👍️0

alstocks 1 year ago

Respectfully disagree….

what you are saying is this, the thinking of

the every day penny/short trader is this

(Especially after 2 monster prs)….

“Omg… it has to fill the gap… I have to sell
At 2.90”

while… I’m saying… and from experience

when a perceived unbelievable Pr comes

out…. Is this:

“Omg, did you see that Pr… I have to buy at
2.90”….

I really don’t think the everyday avg penny

investor is concerned about the “gap”

but what do I know….

Good luck to all

👍️0

surf1944 1 year ago

It is a simple big open gap in CTMX that is closing, it is not shorts, manipulation or a conspiracy.

https://www.nasdaq.com/market-activity/stocks/ctmx/short-interest

https://finance.yahoo.com/quote/CTMX/key-statistics?p=CTMX

https://fintel.io/ss/us/ctmx

👍️ 1

HNDRXX 1 year ago

looks like an easy to borrow stock. i just checked.

👍️0

TheFinalCD 1 year ago

aGREED

👍️0

Triple nickle 1 year ago

Here we go slap the ask

👍️0

alstocks 1 year ago

I went through the same thing after

regeneron PR…. bought in the 1.50’s…

was so disgusted by the manipulation, was

expecting 5 bucks within days/hrs, because

we have seen it before with other stocks on

lesser news…. Saw this shorted all the way

back to 1.33… was close to selling due to

the frustration…. Hang in there is all I can

say…. it just doesn’t seem fair that shorts

can control this stock like this… I mean the

2 prs are literally earth shattering…yet Down

.50 cents after OPEN…. yes very

Frustrating

Good luck to all

👍️0

Triple nickle 1 year ago

It’ll move just be patient
2.45 and boom

👍️0

HNDRXX 1 year ago

had one of the best news any SC can get...

Very disappointing turn of events here

👍️0

Triple nickle 1 year ago

2.45 ? And up

👍️0

Triple nickle 1 year ago

Gettin close to bounce time folks

👍️0

alstocks 1 year ago

Truthfully, not today….

but soon enough…. I’ve seen other stocks

with 1/10 of the impact soar hundreds of

percentage points in 1 day… now ctmx has

given us 2 unbelievable prs…. Yet, somehow

shorts can still manipulate this stock like

they did after the regeneron Pr…. same

thing now…. hit 2.90…. Now at 2.60…

I guess there is not enough massive buying

pressure to overcome the shorts… which I

don’t see how !?!?!? Unbelievable… that’s

why you need to be patient & wait this bull

bleep out…. I mean … legitimately CTMX is

a future 10, 20, higher dollar STOCK

Good luck to all

👍️0

Invest-in-America 1 year ago

CTMX: WHAT is going on over here, Homeboys???? (HA-HA!!)
https://pulse2.com/why-the-cytomx-therapeutics-stock-surged-55-31-after-hours-ctmx/

👍️0

alexjames81 1 year ago

I wanna see 4$ today

👍️0

Triple nickle 1 year ago

We will all be ok here from here
Get what you can
Can all yeah get
And sit on the can

👍️0

alstocks 1 year ago

Don’t let shorts destroy your confidence

in this stock…. They tried after the

regeneron PR… stock sank from 1.90 to

1.33….. AFTER THAT monster PR….

I’m sure they will try it again

Good luck to all

👍️0

alstocks 1 year ago

Let’s hope shorts are not “allowed” to

continue to manipulate this stock….now 2

of the GREATEST pRS ever…. Contract with

regeneron and now moderna where each

company GAVE 30 million each to this tiny

under 5.00 company….. this should go way

up even from opening levels of 2.90

Good luck to all

👍️0

Triple nickle 1 year ago

My trucks around 2.60

👍️0

HNDRXX 1 year ago

I am backing up the truck now at 2.90-3.00

👍️0

TheFinalCD 1 year ago

yep weird action

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CytomX Therapeutics Inc (CTMX)

Get an advanced news scanner tailored to your needs by ADVFN

CTMX News

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

Form S-8 - Securities to be offered to employees in employee benefit plans

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

CytomX Therapeutics to Present at Upcoming March Investor Conferences

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

CTMX Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CytomX Therapeutics Inc (CTMX) News

CytomX Therapeutics Inc (CTMX)

Get an advanced news scanner tailored to your needs by ADVFN

CTMX News

CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors

CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors

CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas

Form S-8 - Securities to be offered to employees in employee benefit plans

CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher

CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

CytomX Therapeutics to Present at Upcoming March Investor Conferences

CytomX Therapeutics Announces FDA Clearance of IND Applications for CX-2051, a Probody® Antibody Drug Conjugate (ADC) Targeting EpCAM and CX-801, a Conditionally Activated Interferon Alpha-2b

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

CTMX Discussion

Your Recent History

Company

Business

Popular

Get The App